Advanced search
Publication Cover
Journal of Asthma Volume 60, 2023 - Issue 11
Submit an article Journal homepage
276
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Efficacy and safety of fixed-dose combination of Bilastine-Montelukast in adult patients with allergic rhinitis: a phase III, randomized, multi-center, double-blind, active controlled clinical study

Shubhadeep D. Sinhaa Department of Clinical Development & Medical Affairs, Hetero, Hyderabad, Telengana, IndiaORCID Iconhttps://orcid.org/0000-0002-1797-3250View further author information
, MBBS, MD, PhD, FCGP, FellDiab, Dip.Diab, PG Diploma (Infectious Diseases), FRSPHORCID Icon,
Sridevi Perapogub Department of ENT, Government Medical College & Hospital, SPSR, Nellore, Andhra Pradesh, IndiaView further author information
, MBBS, MS,
Sreenivasa Chary S.a Department of Clinical Development & Medical Affairs, Hetero, Hyderabad, Telengana, IndiaORCID Iconhttps://orcid.org/0009-0004-7415-7729View further author information
, MBBSORCID Icon,
S. Rameshc Department of ENT, Govt Medical College & Govt General Hospital, Srikakulam, Andhra Pradesh, IndiaView further author information
, MBBS, MS,
Jaimanti Bakshid Department of ENT, Postgraduate Institute of Medical Education and Research, Chandigarh, IndiaView further author information
, MBBS, MS, DNB, MNAMS,
Ajit Singhe Division of Allergy & Pulmonary Medicine, Dhanvantri OPD Block, SMS Hospital, Jaipur, Rajasthan, IndiaView further author information
, MBBS, MD,
Abdul Khabeer Ahmedf Department of ENT, Gandhi Hospital, Secunderabad, Telangana, IndiaView further author information
, MBBS, MS,
B. Mohan Reddya Department of Clinical Development & Medical Affairs, Hetero, Hyderabad, Telengana, IndiaView further author information
, MSc,
Muralidhar Panapakama Department of Clinical Development & Medical Affairs, Hetero, Hyderabad, Telengana, IndiaView further author information
, MSc,
Leela Talluria Department of Clinical Development & Medical Affairs, Hetero, Hyderabad, Telengana, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8503-7897View further author information
, MScORCID Icon &
Ramya Vattipallia Department of Clinical Development & Medical Affairs, Hetero, Hyderabad, Telengana, IndiaView further author information
, MPharm show all
Pages 2014-2020 | Received 31 Jan 2023, Accepted 26 Apr 2023, Published online: 31 May 2023

References

  • Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol. 2001;108(1 Suppl):S2–S8. doi:10.1067/mai.2001.115569.
  • Davies MJ, Fisher LH, Chegini S, Craig TJ. A practical approach to allergic rhinitis and sleep disturbance management. Allergy Asthma Proc. 2006;27(3):224–230. doi:10.2500/aap.2006.27.2858.
  • Lamb CE, Ratner PH, Johnson CE, Ambegaonkar AJ, Joshi AV, Day D, Sampson N, Eng B. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin. 2006;22(6):1203–1210. doi:10.1185/030079906X112552.
  • World Allergy Organization (WAO), White Book on Allergy: 2013. Available from: https://www.worldallergy.org/UserFiles/file/WhiteBook2-2013-v8.pdf [last accessed 9 December 2022].
  • Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A. Preclinical pharmacology of Bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity. Drugs R D. 2005;6(6):371–384. doi:10.2165/00126839-200506060-00005.
  • Farré M, Pérez-Mañá C, Papaseit E, Menoyo E, Pérez M, Martin S, Bullich S, Rojas S, Herance J-R, Trampal C, et al. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers. Br J Clin Pharmacol. 2014;78(5):970–980. doi:10.1111/bcp.12421.
  • Lucero ML, Gonzalo A, Mumford R, Betanzos M, Alejandro A. An overview of Bilastine metabolism during preclinical investigations. Drug Chem Toxicol. 2012;35(sup1):18–24. doi:10.3109/01480545.2012.682651.
  • Tyl B, Kabbaj M, Azzam S, Sologuren A, Valiente R, Reinbolt E, Roupe K, Blanco N, Wheeler W. Lack of significant effect of Bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis. J Clin Pharmacol. 2012;52(6):893–903. doi:10.1177/0091270011407191.
  • Lasseter KC, Sologuren A, La Noce A, Dilzer SC. Evaluation of the single-dose pharmacokinetics of Bilastine in subjects with various degrees of renal insufficiency. Clin Drug Investig. 2013;33(9):665–673. doi:10.1007/s40261-013-0110-0.
  • Storms W. Allergic rhinitis-induced nasal congestion: its impact on sleep quality. Prim Care Respir J. 2008;17(1):7–18. doi:10.3132/pcrj.2008.00001.
  • Meltzer EO, Prenner BM, Nayak AS. Efficacy and tolerability of once-daily 5mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis. Clin Drug Invest. 2001;21(1):25–32. doi:10.2165/00044011-200121010-00004.
  • De Blic J, Wahn U, Billard E, Alt R, Pujazon MC. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol. 2005;16(3):267–275. doi:10.1111/j.1399-3038.2005.00216.x.
  • Gonyeau MJ, Partisano AM. A clinical review of Montelukast in the treatment of seasonal allergic rhinitis. Formulary. 2003;38(6):368–378.
  • Ciebiada M, Gorska-Ciebiada M, Barylski M, Kmiecik T, Gorski P. Use of Montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Am J Rhinol Allergy. 2011;25(1):e1–e6. doi:10.2500/ajra.2011.25.3540.
  • Clinical Trials Registry - India. Available from: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=37391&EncHid=&user Name=bilastine [last accessed 4 January 2023].
  • Lynde CW, Sussman G, Dion P-L, Guenther L, Hébert J, Rao J, Leek TV, Waserman S. Multidisciplinary real-world experience with Bilastine, a second generation antihistamine. J Drugs Dermatol. 2020;19(2):145–154. doi:10.36849/JDD.2020.4835.
  • Adsule SM, Misra D. Long term treatment with Montelukast and levocetirizine combination in persistent allergic rhinitis: review of recent evidence. J Indian Med Assoc. 2010;108(6):381–382.
  • Rajashekar YR, Shobha SN. Randomized prospective double-blind comparative clinical study of ebastine and its combined preparation of Montelukast in persistent allergic rhinitis. Natl J Physiol Pharm Pharmacol. 2018;8(3):319–324.
  • Gupta V, Matreja PS. Efficacy of montelukat and levocitrizine as treatment for allergic rhinitis. J Allergy Ther. 2010;1(1):103.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.